Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial

Name: Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: VOL 49 No. 1 Articles 2019 Tags: Amit Anand, electroconvulsive-therapy, glutamate, Harish Karne, ketamine, Murat Altinay, treatment-resistant-depression

Description
Reviews (0)

Description

Original Research

Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial

By Murat Altinay, Harish Karne, Amit Anand

08-16_PB-49-1-2019-Altinay

Reviews

There are no reviews yet.

Be the first to review “Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial”

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial

Description

Original Research

Reviews

Related products

P. Murali Doraiswamy, MD: Alzheimer’s Disease and the Glutamate NMDA Receptor

Psychopharmacology Bulletin VOL 46 No. 2 – Full Issue Stacked PDF

An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome

Treatment Resistant Depression with Loss of Antidepressant Response: Rapid—Acting Antidepressant Action of Dextromethorphan, A Possible Treatment Bridging Molecule